Access to Medicine

2021/01/26 - In our company, we believe in science as a force for good. We are proud to rank in the top ten of the 2021 ATM Index.

Access to Medicine

Every two years, the Access to Medicine Foundation, an independent non-profit organization founded in 2005, benchmarks 20 of the world’s largest pharmaceutical companies based on their efforts to advance global access to medicines. Our company is committed to improving sustainable access to high-quality solutions for all communities and patients in need.

We came in eighth place and are thus again among the top ten companies in 2021

The current index particularly recognized our performance in Research & Development – where we ranked fifth. This is an excellent result for our company. We also received accolades for our leading role in Intellectual Property sharing, which includes for instance strategic collaborations to fight the Covid-19 pandemic and to advance research in infectious diseases. We also performed well with our mechanisms to guarantee the supply of medicines to low- and middle-income countries and for our donations in response to patients’ needs.

Facts & Figures

  • 106

    low- and middle-income countries were in the scope of the 2021 ATM Index

  • 82

    diseases were in the scope of the 2021 ATM Index

  1. Press Releases

    Merck KGaA, Darmstadt, Germany Ranks Fourth in 2018 Access to Medicine Index ...

    Merck KGaA, Darmstadt, Germany, today announced that it ranks fourth in the 2018 Access to Medicine Index, maintaining its ranking among the top five since the last Index in 2016.

    2018/11/20

  2. Press Releases

    Merck KGaA, Darmstadt, Germany Ranks Fourth in 2016 Access to Medicine Index

    Merck KGaA, Darmstadt, Germany a leading science and technology company, announced today it now ranks fourth in the 2016 Access to Medicine Index, climbing two ranks since the last Index in 2014.

    2016/11/14

Timo Breiner

Manager News & Media Relations